Neurodegeneration Research

Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS are marked by progressive neuronal damage and overlapping proteinopathies. This brochure explores key biomarkers—Amyloid-beta, TAU, α-Synuclein, TDP43, and Neurofilament Light—and their roles in disease characterization and differentiation. It highlights the diagnostic value of cerebrospinal fluid and blood-based assays, emphasizing how pre-analytical immunoprecipitation significantly enhances sensitivity and specificity in detecting Alzheimer’s-related biomarkers. Gain insight into a comprehensive portfolio of ELISA and IP-based tools for measuring these biomarkers across various sample types, including plasma and CSF.

Access the full brochure to see how biomarker precision is advancing neurodegeneration research.